(Total Views: 101)
Posted On: 07/06/2023 3:00:45 PM
Post# of 27115

$CLDX News Article - Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Eosinophilic Esophagitis https://marketwirenews.com/news-releases/cell...43177.html


My Twitter: WhyteStocks